Press release
May 21, 2026
Enliven Therapeutics to Present at Upcoming Investor Conferences
Enliven Therapeutics, Inc. (ELVN)
BOULDER, Colo., May 21, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in the following